Industri

DFE Pharma launches EcoLact 2030 for lactose excipients

Programme provides CO₂ data and value-chain traceability The post DFE Pharma la...

Report maps non-animal testing methods for drug develop...

Study outlines role of NAMs in pharma and MedTech research The post Report map...

Heart Month 2026: Why Heart Health Deserves Year-Round ...

Every February, Heart Month reminds us to pause and reflect on one of our most v...

Pinwheel Therapeutics raises $20mn from 108 BioCapital

Funding linked to late-stage clinical asset transaction The post Pinwheel Thera...

Lupin launches Topiramate Extended-Release Capsules in ...

Launch follows FDA approval for ANDA The post Lupin launches Topiramate Extend...

Relay Therapeutics’ zovegalisib secures FDA BTD for adv...

The designation covers adults with phosphatidylinositol-4,5-bisphosphate 3-kinas...

Zydus receives USFDA tentative approval for dapaglifloz...

Approval covers 5 mg and 10 mg strengths for US market The post Zydus receives...

CEPI and Samsung Biologics partner to boost global vacc...

Samsung Biologics is set to become part of CEPI’s Vaccine Manufacturing Facility...

UP Pharma Conclave 1.0 inaugurated in Lucknow; Gov outl...

CM Yogi Adityanath sets out policy framework, law and order measures, and pharm...

CDSCO approves durvalumab with FLOT for resectable gast...

Approval based on phase III MATTERHORN study supports perioperative use The pos...

Sun Pharma named principal sponsor and health partner o...

Three-year partnership marks Sun Pharma’s first cricket sponsorship The post Su...

Friendshoring: Pharma’s next supply chain bet?

With friendshoring gaining attention in global supply chain conversations, this...

SanegeneBio and Genentech sign $1.5bn global RNAi licen...

The deal grants Genentech exclusive global rights to develop and commercialise t...

Quality, Manufacturing, and Compliance: The Standards B...

Quality manufacturing and compliance MVS Omega-3: For food supplements, quality ...

Aquestive receives FDA CRL for Anaphylm allergic reacti...

The therapy aims to treat Type I allergic reactions, including anaphylaxis, in p...

SPARC receives Priority Review Voucher associated with ...

Sun Pharma Advanced Research Company (SPARC) announced  that the United States ...